Leukemia
Leukemia is a malignancy that typically develops in the bone marrow, which produces blood. It causes an excess of aberrant white blood cells, a component of the immune system that protects the body from infection, to be produced.
- Oncogene
- Pancreatic and Colorectal Cancer
- Gynecologic Oncology
- Melanoma and Carcinoma
- Molecular & Cancer Biomarkers
- Leukemia and Bone marrow Transplantation
- Neoplasms
- Biomedical Research
Related Conference of Leukemia
Leukemia Conference Speakers
Recommended Sessions
- Anemia
- Biomarkers in Hematology
- Bleeding Disorders
- Clinical and Experimental Hematology
- Coagulopathies
- Gene and Cell Therapies for Blood Disorders
- Hematologic Malignancies
- Hematology and neurological disorders
- Hematology in COVID-19 patients
- Hematology in Pediatrics
- Hematology-oncology
- Hematopoietic Stem Cell Transplantation
- Hemostasis
- HIV/AIDS
- Immunohematology
- Immunotherapy for Blood Disorders
- Leukemia
- Myeloma
- Rare Blood Disorders
- Thalassemia
- Thrombosis and Hemostasis
Related Journals
Are you interested in
- Advances in Hematologic Malignancies - Blood Disorders 2025 (France)
- Advances in Hemostasis and Thrombosis - Blood Disorders 2025 (France)
- Biomarkers in Hematology and Oncology - Hematology Congress 2026 (Germany)
- Blood Disorders and the Immune System - Blood Disorders 2025 (France)
- Blood Disorders in Aging Populations - Blood Disorders 2025 (France)
- Blood Disorders: Diagnosis and Treatment - Hematology Congress 2026 (Germany)
- Cancer Genomics & Metabolomics - Hematology Congress 2026 (Germany)
- Case Reports in Hematology - Hematology Congress 2026 (Germany)
- Clinical Haematology - Hematology Congress 2026 (Germany)
- Cord Blood Transplantation - Hematology Congress 2026 (Germany)
- Cutting-Edge Research in Blood Disorders - Blood Disorders 2025 (France)
- Digital Imaging in Hematology - Hematology Congress 2026 (Germany)
- Future Trends in Hematology: Artificial Intelligence and Big Data - Blood Disorders 2025 (France)
- Gene Therapy and Genetic Engineering in Hematology - Blood Disorders 2025 (France)
- Haematology and Pharma Industry - Hematology Congress 2026 (Germany)
- Hematologic Cancers - Hematology Congress 2026 (Germany)
- Hematologic Toxicities and Side Effects of Cancer Therapy - Blood Disorders 2025 (France)
- Hematology and Cardio-Oncology - Hematology Congress 2026 (Germany)
- Hematology in Global Health: Addressing Disparities - Blood Disorders 2025 (France)
- Hematology Nursing - Hematology Congress 2026 (Germany)
- Hematology: Diagnostics and Screening - Hematology Congress 2026 (Germany)
- Hematopoietic Malignancies - Hematology Congress 2026 (Germany)
- Immunohematology - Hematology Congress 2026 (Germany)
- Immunotherapy and Cellular Therapies in Hematology - Blood Disorders 2025 (France)
- Innovations in Red Blood Cell Disorders - Blood Disorders 2025 (France)
- Neuro-Hematology - Hematology Congress 2026 (Germany)
- Novel Diagnostic Techniques and Biomarkers in Hematology - Blood Disorders 2025 (France)
- Organ Specific Cancer - Hematology Congress 2026 (Germany)
- Pediatric Hematology - Hematology Congress 2026 (Germany)
- Pediatric Hematology: Challenges and Innovations - Blood Disorders 2025 (France)
- Stem Cell Therapy - Hematology Congress 2026 (Germany)
- Stem Cell Transplantation and Regenerative Medicine - Blood Disorders 2025 (France)
- Transfusion Medicine: Advances and Challenge - Blood Disorders 2025 (France)
- Transfusion Medicines - Hematology Congress 2026 (Germany)
- Vascular Bleeding Disorders - Hematology Congress 2026 (Germany)